成人急性髓系白血病单纯4、8、11、13或21号染色体三体的临床与分子特征
该研究分析了138例携带单纯+4、+8、+11、+13或+21的成人原发AML患者的临床与分子特征,并与非单纯三体及细胞遗传学正常AML患者比较。发现甲基化相关基因突变是各单纯三体组的共同分子标志,剪接体基因突变在除外+4的单纯三体组中常见,且单纯三体组剪接体突变频率显著高于非单纯三体组和CN-AML组。
要点
- 甲基化相关基因突变是单纯三体AML的分子标志,各组频率55%-75%。
- 除外+4的单纯三体患者剪接体基因突变常见(43%-65%)。
- +4患者多见转录因子基因(44%)和NPM1(36%)突变。
核心结论
- 甲基化相关基因突变是单纯三体AML的分子标志,剪接体基因突变是该细胞遗传学亚组的新发现。
研究设计与样本
- 回顾性分析138例成人原发AML患者,携带单纯+4、+8、+11、+13或+21,并与非单纯三体(n=131)和CN-AML(n=716)患者比较。
主要发现
- 各单纯三体组甲基化相关基因突变频率为+4 55%、+8 58%、+11 71%、+13 71%、+21 75%。
- 除外+4的单纯三体组剪接体基因突变频率为+8 43%、+11 65%、+13 65%、+21 45%。
- +4患者转录因子基因突变频率44%,NPM1突变频率36%。
- 单纯三体组48%携带剪接体基因突变,非单纯三体组为24%(P<0.001),CN-AML组为19%(P<0.001)。
临床怎么用
- 对单纯+4、+8、+11、+13或+21的AML患者应关注甲基化相关基因和剪接体基因突变检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sole trisomies of chromosomes 4, 8, 11, 13 and 21 account for 89-95% of all sole trisomies in adult AML patients. We analyzed clinical and molecular characteristics of 138 de novo AML patients with sole +4, +8, +11, +13 or +21, and compared them with AML patients with those trisomies occurring in addition to other chromosome abnormalities (non-sole trisomy) and with cytogenetically normal AML (CN-AML) patients. Mutations in methylation-related genes were most commonly observed within each sole trisomy group (+4, 55%; +8, 58%; +11, 71%; +13, 71%; +21, 75% of patients). Patients with sole trisomies, excluding +4, also had frequent mutations in spliceosome genes (+8, 43%; +11, 65%; +13, 65%; +21, 45% of patients). In contrast, +4 patients frequently had mutations in transcription factor genes (44%) and NPM1 (36%). While 48% of patients with sole trisomies harbored mutations in a spliceosome gene, spliceosome mutations were observed in only 24% of non-sole trisomy (n = 131, P < 0.001) and 19% of CN-AML patients (n = 716, P < 0.001). Our data suggest that mutations affecting methylation-related genes are a molecular hallmark of sole trisomies. Mutations in spliceosome genes were also commonly observed in many sole trisomy patients and represent a novel finding in this cytogenetic subgroup.
引用
- Bhatnagar B, Eisfeld AK, Kohlschmidt J, et al. Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21. Leukemia. 2019. PMID: 31462731. doi:10.1038/s41375-019-0560-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。